Furthermore, genistein may synergize with bisphosphonate alendronate to inhibit the osteoclastic differentiation induced by RANKL, which providing a novel strategy for clinic prevention and treatment of osteoporosis (Yamaguchi and Levy, 2017) (Table 1). Here, TNFSF11 is linked to osteoporosis.